Clinical Trials Browser

Phase 3 × INDUSTRY × Pluvicto × Clear all

NCT04720157 2026-03-11

PSMAddition

Phase 3 Active not recruiting

Prostatic Neoplasms

NCT04689828 2026-02-20

PSMAfore

Phase 3 Active not recruiting

469 enrolled 11 charts 1 FDA

Prostatic Neoplasms

NCT03511664 2025-01-13

VISION

Phase 3 Completed

861 enrolled 39 charts 1 FDA

Prostatic Neoplasms